All In MedTech

Device Trial Radar · NCT06150274

Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy

Simplifying Percutaneous Balloon Mitral Valvulotomy (PBMV) to Reduce the Burden of Mitral Stenosis in Sub-Saharan Africa.

Last checked: Nov 20, 2026Latest source record: Jun 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

May 24, 2024

Primary completion

May 31, 2024

Study completion Jun 3, 2024

Sponsor

Lead sponsor
Helse Stavanger HFGovernment (non-federal)
Sponsor type
Government (non-federal)
Collaborators
Haukeland University Hospital
First posted
Nov 29, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomised study is comparison of wire assisted balloon mitral valvulotomy to standard Inoue balloon technique on patients with rheumatic mitral stenosis. The main question it aims to answer is whether procedure time is reduced using the wire assisted method. Participants will be randomized to one of the two methods.

Conditions

  • Rheumatic Heart Disease

Interventions

  • Percutaneous Balloon Mitral ValvulotomyDevice

    Stenotic mitral valve will be dilated to open the commissures

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction in procedure durationTime frame: day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tikur Anbessa Specialized Hospital

    Addis Ababa, Addis Ababa, Ethiopia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.